Cost impact of COPD in Japan: Opportunities and challenges?

Respirology

Volumn 9, Issue 4, 2004, Pages 466-473

  Nishimura, Shuzo ^a   Zaher, Carol ^b  

^a KYOTO UNIVERSITY   (Japan)

^b Cerner Health Insights   (United States)

Author keywords

COPD; Cost of care; Disease burden; Pharmacoeconomics

Indexed keywords

RESPIRATORY TRACT AGENT;

ABSENTEEISM; ADULT; ARTICLE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISABILITY; DISEASE SEVERITY; EARLY DIAGNOSIS; FORCED EXPIRATORY VOLUME; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH SURVEY; HOME CARE; HOSPITAL CARE; HUMAN; JAPAN; LENGTH OF STAY; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MEDLINE; MODEL; OUTPATIENT CARE; OXYGEN THERAPY; PATIENT EDUCATION; PREVALENCE; PRIORITY JOURNAL; PRODUCTIVITY;

ABSENTEEISM; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; JAPAN; MODELS, ECONOMIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 13144281716     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2004.00617.x     Document Type: Article

References (24)

1. Murray CJL, Lopez AD (eds). The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Harvard University Press, Cambridge. 1996.
2. National Heart, Lung and Blood Institute. Morbidity and Mortality: 2002 Chart Book on Cardiovascular, Lung, and Blood Diseases. National Institutes of Health, National Heart, Lung and Blood Institute, Rockville. May 2002.
3. Institute of Medicine. Crossing the Quality Chasm: a New Health System for the 21st Century. National Academy Press, Washington DC. 2001.
4. The National Lung Health Education Program Executive Committee. Strategies in preserving lung health and preventing COPD and associated diseases. The National Lung Health Education Program (NLHEP). Chest 1998; 113(2Suppl.): 123S-163S.
5. Petty TL, Weinmann GG. Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease. JAMA 1997; 277: 246-53.
6. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: NHLBI/WHO, Workshop Report. NIH Publication no. 2701. DHHS, National Institutes of Health, Bethesda. 2001. Available at URL: http://www.goldcopd.com
7. Fukuchi Y, Nishimura M, Ichinose M et al. COPD in Japan: the Nippon COPD Epidemiology study. Respirology 2004; 9: 458-465.
8. Japanese Respiratory Society. Guideline for Chronic Obstructive Pulmonary Disease Diagnosis and Management. Nihon Kokyuki Gakkai Zasshi Supplement March 1999; 1-95.
9. Nippon Boehringer Ingelheim. Data on file.
10. Kotake Y, Kikuchi H, Katsura H et al. A study of medical costs in chronic obstructive pulmonary disease (COPD) and bronchial asthma in Japanese elderly. Am. J. Respir. Crit. Care Med. 1999; Supplement: A805.
11. Izumi T. COPD therapy problems in Japan from the view point of medical expenditure. Geriatric Med. 1999; 37: 1721-8 (in Japanese).
12. Social Service Research Information (SSRI). Results of survey of patients with respiratory problems, 1999. Nippon Boehringer Ingelheim. Data on file.
13. Izumi T. Chronic obstructive pulmonary disease in Japan. Curr. Opin. Pulm. Med. 2002; 8: 102-5.
14. Motegi T, Kida K. Clinical epidemiology of chronic obstructive pulmonary disease. Nippon Rinsho 1999; 57: 1950-3 (in Japanese).
15. Based on Japanese per capita income for 1999. Asian economic survey. Asian Wall Street Journal October 23 2000; S17.
16. Wilson L, Devine EB, So K. Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema. Respir. Med. 2000; 94: 204-13.
17. Strassels SA, Smith DH, Sullivan SD, Mahajan PS. The costs of treating COPD in the United States. Chest 2001; 119: 344-52.
18. Guest JF. The annual cost of chronic obstructive pulmonary disease to the UK's National Health Service. Dis. Manag. Health Outcomes 1999; 5: 93-100.
19. Sullivan SD, Strassels SA, Smith DH. Characterization of the costs of chronic obstructive pulmonary disease (COPD) in the US. Eur. Respir. J. Suppl. 1996; 23: 421S.
20. National Heart Lung and Blood Institute. Morbidity and Mortality: 1998 Chart Book on Cardiovascular, Lung, and Blood Diseases. US Department of Health and Human Services, Public Health Service, National Institute of Health, Rockville, MD, October 1998.
21. Calverly PMA. Chronic Obstructive Pulmonary Disease, the key facts. British Lung Foundation, London. 1998.
22. Jacobson L, Hertzman P, Lofdahl CG, Skoogh BE, Lindgren B. The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991. Respir. Med. 2000; 94: 247-55.
23. Tsuji I, Kuwahara A, Nishino Y, Ohkubo T, Sasaki A, Hisamichi S. Medical cost for disability: a longitudinal observation of National Health Insurance beneficiaries in Japan. J. Am. Geriatr. Soc. 1999; 47: 470-6.
24. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498-504.